Local 12: New research could help treat cocaine use disorder by targeting brain
UC researcher takes novel approach to studying addiction
For more than 50 years, the conventional wisdom in the field of research in cocaine use has been that people take cocaine based on the theory of the drug providing positive reinforcement to the user.
New research out of the University of Cincinnati shows that a pharmacological equation disproves that concept and could spark a major shift in that field of research. Local 12 produced a story about the study, interviewing lead researcher Andrew Norman, PhD, of the Department of Pharmacology and Systems Physiology at the UC College of Medicine.
Norman's research about how people get hooked on cocaine is different than how most researchers see it. He said it’s that the drug reinforces pleasure centers in the brain. “It may be pleasurable, it may induce positive effects, but that isn’t the reason why animals or people will take it,” said Norman.
Andrew Norman, PhD, of the Department of Pharmacology and Systems Physiology/Photo/Colleen Kelley/UC Marketing + Brand
Instead, his lab experiments show it’s because of the effect of the drug itself.
“And so, it doesn’t matter whether you want the cocaine or not. It will drive the behavior, just like all drugs do. There is no choice in pharmacology,” Norman said.
He said much like sleeping pills, if a person takes them, he or she will fall asleep whether they want to or not.
“The drug is exerting its effect, and that is a fundamental departure from the standard way of looking at it, where it’s a choice whether we take the drug or not,” Norman said.
To interrupt that process, Dr. Norman’s team has developed a treatment. He hopes to soon test it in human trials. It would target and reduce concentrations of the drug at the site of action in the brain. That will hopefully lead to reduced use and long-term addiction recovery. This also likely has implications for other drugs.
Read more about Norman's addiction research here.
Lead photo/Nur Ceren Demir/iStock
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
University of Cincinnati gets $1.1M for AI physician training
January 30, 2026
The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.
Hoxworth Blood Center teams up with Cyclones in February for biggest blood drive event of year
January 30, 2026
Hoxworth Blood Center, University of Cincinnati, is teaming up with the Cyclones and other local businesses to host its annual Queen City Blood Drive on Feb. 9-11 at Heritage Bank Center. If you can’t attend this event, Hoxworth encourages you to still make donating a #HoxworthHabit and give blood this February.
Research findings may lead to new test for endometriosis
January 30, 2026
Endometriosis affects one in 10 women worldwide, and many go years before diagnosis. Symptoms include chronic pelvic pain, heavy bleeding during menstruation and/or sexual intercourse, bloating and fatigue. Katie Burns’ research at the University of Cincinnati is focused on creating a new, non-invasive test for endometriosis, using white blood cells as biomarkers. Burns, PhD, is an associate professor in the Department of Environmental and Public Health Sciences in the College of Medicine.